The Role of Matrix Metalloproteinase-9 (MMP-9) as a Prognostic Factor in Epithelial and Lymphatic Neoplasia

Chirurgia (Bucharest, Romania : 1990)
|December 30, 2015
PubMed

Insights

Matrix metalloproteinase 9 (MMP-9) is a key enzyme in cancer invasion and metastasis. This review confirms MMP-9 expression as a significant indicator of poor survival in pelvic-abdominal epithelial and lymphatic cancers.

Area of Science:

  • Oncology
  • Biochemistry
  • Cancer Research

Background:

  • Matrix metalloproteinase 9 (MMP-9) is an enzyme crucial for extracellular matrix remodeling.
  • MMP-9 plays a significant role in cancer cell invasion and the metastatic process.

Purpose of the Study:

  • To evaluate the expression of MMP-9.
  • To determine the prognostic value of MMP-9 in common pelvic-abdominal epithelial and lymphatic neoplasias.

Main Methods:

  • Systematic review of 19 studies.
  • Analysis included data from 1523 patients.
  • Studies published between January 1995 and July 2015.

Main Results:

  • MMP-9 expression was analyzed in various epithelial and lymphatic cancers.
  • A significant correlation was found between MMP-9 expression and patient survival.
  • MMP-9 is a valid marker for predicting poor survival outcomes.

Conclusions:

  • MMP-9 expression is a valuable prognostic marker in pelvic-abdominal cancers.
  • Elevated MMP-9 levels indicate a poorer prognosis for patients.
  • Further research can explore therapeutic strategies targeting MMP-9.